{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:58:51Z","timestamp":1789250331769,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004168","name":"Universit\u00e4t zu L\u00fcbeck","doi-asserted-by":"publisher","award":["E27-2010"],"award-info":[{"award-number":["E27-2010"]}],"id":[{"id":"10.13039\/501100004168","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU08.826"],"award-info":[{"award-number":["TTU08.826"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004168","name":"Universit\u00e4t zu L\u00fcbeck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004168","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Patients with otitis media (OM) encounter significant functional hearing impairment with conductive, or a combined hearing loss and long-term sequelae involving impaired speech\/language development in children, reduced academic achievement and irreversible disorders of middle and inner ear requiring a long time therapy and\/or multiple surgeries. In its persistent chronic form, Otitis media (COM) can often only be treated by undergoing ear surgery for hearing restoration. The persistent inflammatory reaction plays a major role, often caused by multi-resistant pathogens in the ear. Herein, we present outcomes of patients implanted with currently the only FDA approved active Middle Ear Implant Vibrant Soundbridge (VSB), suffering from persistent COM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study enrolled 42 patients, treated by performing middle ear (ME) surgery to different extents and implanted with the VSB to various structures in the ME. Included were 17 children and 25 adults that had recurrent and\/or persisting OM and significant hearing loss. Preoperative and postoperative patients' audiometric data were evaluated and the benefit with VSB assessed using the Glasgow Benefit Inventory for adults and pediatric cohorts. The microbial spectrum of pathogens was assessed before and after surgery, exploring the colonization of the otopathogens, as well as the intestinal microbiome from individually burdened patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean functional gain is 29.7\u00a0dB HL (range from 10 to 56.2\u00a0dB HL) with a significant improvement in speech intelligibility in quiet. Following VSB implantation, no significant differences in coupling were observed at low complication rates. Postoperatively patients showed significantly increased benefit with VSB compared to the untreated situation, including less otorrhea, pain, medical visits, and medication intake, with no recurrent OM and significant bacterial shift in otopathogens. The analysis of the intestinal microbiome displayed a high abundance of bacterial strains that might be linked to chronic and persistent inflammation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Functional ear surgery including rehabilitation with a VSB in patients suffering from COM present to be safe and effective. The successful acceptance accompanied by the improved audiological performance resulted in significant benefit with VSB, with a shift in the ear pathogens and altered microbiome and thus is a great opportunity to be treated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00405-022-07795-9","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T07:47:18Z","timestamp":1674200838000},"page":"3107-3118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hearing rehabilitation and microbial shift after middle ear surgery with Vibrant Soundbridge in patients with chronic otitis media"],"prefix":"10.1007","volume":"280","author":[{"given":"Karl-Ludwig","family":"Bruchhage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Lupatsii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"M\u00f6llenkolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Kurabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"J\u00fcrgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Graspeuntner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Hollfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8067-4299","authenticated-orcid":false,"given":"Anke","family":"Leichtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"7795_CR1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.ijporl.2010.09.022","volume":"74","author":"A Arguedas","year":"2010","unstructured":"Arguedas A, Kvaerner K, Liese J et al (2010) Otitis media across nine countries: disease burden and management. Int J Pediatr Otorhinolaryngol 74:1419\u20131424. https:\/\/doi.org\/10.1016\/j.ijporl.2010.09.022","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"7795_CR2","doi-asserted-by":"publisher","first-page":"16063","DOI":"10.1038\/nrdp.2016.63","volume":"2","author":"AGM Schilder","year":"2016","unstructured":"Schilder AGM, Chonmaitree T, Cripps AW et al (2016) Otitis media. Nat Rev Dis Primers 2:16063. https:\/\/doi.org\/10.1038\/nrdp.2016.63","journal-title":"Nat Rev Dis Primers"},{"key":"7795_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/lary.24190","volume":"124","author":"S Ahmed","year":"2014","unstructured":"Ahmed S, Shapiro NL, Bhattacharyya N (2014) Incremental health care utilization and costs for acute otitis media in children. Laryngoscope 124:301\u2013305. https:\/\/doi.org\/10.1002\/lary.24190","journal-title":"Laryngoscope"},{"key":"7795_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/MAO.0b013e318259533f","volume":"33","author":"H Lampikoski","year":"2012","unstructured":"Lampikoski H, Aarnisalo AA, Jero J et al (2012) Mastoid biofilm in chronic otitis media. Otol Neurotol 33:785\u2013788. https:\/\/doi.org\/10.1097\/MAO.0b013e318259533f","journal-title":"Otol Neurotol"},{"key":"7795_CR5","unstructured":"Morris P (2012) Chronic suppurative otitis media. BMJ Clin Evid 2012:0507"},{"key":"7795_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1099\/jmm.0.000155","volume":"64","author":"R Mittal","year":"2015","unstructured":"Mittal R, Lisi CV, Gerring R et al (2015) Current concepts in the pathogenesis and treatment of chronic suppurative otitis media. J Med Microbiol 64:1103\u20131116. https:\/\/doi.org\/10.1099\/jmm.0.000155","journal-title":"J Med Microbiol"},{"key":"7795_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.humimm.2014.05.009","volume":"75","author":"Y Si","year":"2014","unstructured":"Si Y, Zhang ZG, Chen SJ et al (2014) Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media. Hum Immunol 75:771\u2013776. https:\/\/doi.org\/10.1016\/j.humimm.2014.05.009","journal-title":"Hum Immunol"},{"key":"7795_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2172-12-12","volume":"12","author":"J Ebmeyer","year":"2011","unstructured":"Ebmeyer J, Leichtle A, Hernandez M et al (2011) TNFA deletion alters apoptosis as well as caspase 3 and 4 expression during otitis media. BMC Immunol 12:12. https:\/\/doi.org\/10.1186\/1471-2172-12-12","journal-title":"BMC Immunol"},{"key":"7795_CR9","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1097\/MAO.0000000000000558","volume":"35","author":"RA Chole","year":"2014","unstructured":"Chole RA, Gagnon PM, Vogel JP (2014) Inactivation of specific Pseudomonas aeruginosa biofilm factors does not alter virulence in infected cholesteatomas. Otol Neurotol 35:1585\u20131591. https:\/\/doi.org\/10.1097\/MAO.0000000000000558","journal-title":"Otol Neurotol"},{"key":"7795_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/408169","author":"A Leichtle","year":"2015","unstructured":"Leichtle A, Klenke C, Ebmeyer J et al (2015) NOD-Like receptor signaling in cholesteatoma. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/408169","journal-title":"Biomed Res Int"},{"key":"7795_CR11","doi-asserted-by":"publisher","first-page":"16683","DOI":"10.1038\/srep16683","volume":"5","author":"Y Si","year":"2015","unstructured":"Si Y, Chen YB, Chen SJ et al (2015) TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction. Sci Rep 5:16683. https:\/\/doi.org\/10.1038\/srep16683","journal-title":"Sci Rep"},{"key":"7795_CR12","first-page":"197","volume":"29","author":"F Ricciardiello","year":"2009","unstructured":"Ricciardiello F, Cavaliere M, Mesolella M et al (2009) Notes on the microbiology of cholesteatoma: clinical findings and treatment. Acta Otorhinolaryngol Ital 29:197\u2013202","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"7795_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10162-008-0153-8","volume":"10","author":"R Nason","year":"2009","unstructured":"Nason R, Jung JY, Chole RA (2009) Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol 10:151\u2013160. https:\/\/doi.org\/10.1007\/s10162-008-0153-8","journal-title":"J Assoc Res Otolaryngol"},{"key":"7795_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010199","author":"M Sch\u00fcrmann","year":"2020","unstructured":"Sch\u00fcrmann M, Greiner JFW, Volland-Thurn V et al (2020) Stem cell-induced inflammation in cholesteatoma is inhibited by the TLR4 antagonist LPS-RS. Cells. https:\/\/doi.org\/10.3390\/cells9010199","journal-title":"Cells"},{"key":"7795_CR15","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/lary.22189","volume":"121","author":"JY Jung","year":"2011","unstructured":"Jung JY, Lee DH, Wang EW et al (2011) P. aeruginosa infection increases morbidity in experimental cholesteatomas. Laryngoscope 121:2449\u20132454. https:\/\/doi.org\/10.1002\/lary.22189","journal-title":"Laryngoscope"},{"key":"7795_CR16","unstructured":"Deutsche Gesellschaft f\u00fcr Hals-Nasen-Ohrenheilkunde 017-074_S2K-Leitlinie_Chronisch-mesotympanale-Otitis-media_Stand 10\/2020"},{"key":"7795_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13059-021-02496-8","volume":"22","author":"X Ke","year":"2021","unstructured":"Ke X, You K, Pichaud M et al (2021) Gut bacterial metabolites modulate endoplasmic reticulum stress. Genome Biol 22:292. https:\/\/doi.org\/10.1186\/s13059-021-02496-8","journal-title":"Genome Biol"},{"key":"7795_CR18","doi-asserted-by":"publisher","first-page":"683068","DOI":"10.3389\/fimmu.2021.683068","volume":"12","author":"L van Olst","year":"2021","unstructured":"van Olst L, Roks SJM, Kamermans A et al (2021) Contribution of gut microbiota to immunological changes in Alzheimer\u2019s disease. Front Immunol 12:683068. https:\/\/doi.org\/10.3389\/fimmu.2021.683068","journal-title":"Front Immunol"},{"key":"7795_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22095005","author":"I Yusufu","year":"2021","unstructured":"Yusufu I, Ding K, Smith K et al (2021) A tryptophan-deficient diet induces gut microbiota dysbiosis and increases systemic inflammation in aged mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22095005","journal-title":"Int J Mol Sci"},{"key":"7795_CR20","first-page":"280","volume":"39","author":"D Hall","year":"1997","unstructured":"Hall D (1997) Otitis media with effusion. Dev Med Child Neurol 39:280","journal-title":"Dev Med Child Neurol"},{"key":"7795_CR21","first-page":"108","volume":"74","author":"MM Paparella","year":"1970","unstructured":"Paparella MM, Brady DR, Hoel R (1970) Sensori-neural hearing loss in chronic otitis media and mastoiditis. Trans Am Acad Ophthalmol Otolaryngol 74:108\u2013115","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"7795_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/854024","author":"C-L Kuo","year":"2015","unstructured":"Kuo C-L, Shiao A-S, Yung M et al (2015) Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/854024","journal-title":"Biomed Res Int"},{"key":"7795_CR23","doi-asserted-by":"publisher","DOI":"10.1055\/a-1516-4447","author":"A Leichtle","year":"2021","unstructured":"Leichtle A, Leffers D, Daerr MG et al (2021) Immunmodulation im Cholesteatom (Immunomodulation in Cholesteatoma). Laryngorhinootologie. https:\/\/doi.org\/10.1055\/a-1516-4447","journal-title":"Laryngorhinootologie"},{"key":"7795_CR24","unstructured":"Deutsche Gesellschaft f\u00fcr Hals-Nasen-Ohrenheilkunde 017\/006S1-Leitlinie Cholesteatom_Stand 06\/2014"},{"key":"7795_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000318521","volume":"69","author":"W-D Baumgartner","year":"2010","unstructured":"Baumgartner W-D, B\u00f6heim K, Hagen R et al (2010) The vibrant soundbridge for conductive and mixed hearing losses: European multicenter study results. Adv Otorhinolaryngol 69:38\u201350. https:\/\/doi.org\/10.1159\/000318521","journal-title":"Adv Otorhinolaryngol"},{"key":"7795_CR26","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.ijporl.2010.07.028","volume":"74","author":"CWRJ Cremers","year":"2010","unstructured":"Cremers CWRJ, O\u2019Connor AF, Helms J et al (2010) International consensus on Vibrant Soundbridge\u00ae implantation in children and adolescents. Int J Pediatr Otorhinolaryngol 74:1267\u20131269. https:\/\/doi.org\/10.1016\/j.ijporl.2010.07.028","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"7795_CR27","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/MAO.0000000000000796","volume":"36","author":"H Frenzel","year":"2015","unstructured":"Frenzel H, Sprinzl G, Streitberger C et al (2015) The vibrant soundbridge in children and adolescents: preliminary European multicenter results. Otol Neurotol 36:1216\u20131222. https:\/\/doi.org\/10.1097\/MAO.0000000000000796","journal-title":"Otol Neurotol"},{"key":"7795_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/00129492-200111000-00042","volume":"22","author":"U Fisch","year":"2001","unstructured":"Fisch U, Cremers CW, Lenarz T et al (2001) Clinical experience with the Vibrant Soundbridge implant device. Otol Neurotol 22:962\u2013972. https:\/\/doi.org\/10.1097\/00129492-200111000-00042","journal-title":"Otol Neurotol"},{"key":"7795_CR29","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/00129492-200111000-00041","volume":"22","author":"B Fraysse","year":"2001","unstructured":"Fraysse B, Lavieille JP, Schmerber S et al (2001) A multicenter study of the Vibrant Soundbridge middle ear implant: early clinical results and experience. Otol Neurotol 22:952\u2013961. https:\/\/doi.org\/10.1097\/00129492-200111000-00041","journal-title":"Otol Neurotol"},{"key":"7795_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0030-6665(05)70337-6","volume":"34","author":"FM Snik","year":"2001","unstructured":"Snik FM, Mylanus AM, Cremers W et al (2001) Multicenter audiometric results with the vibrant soundbridge,* *Symphonix Devices, San Jose, CA. a semi-implantable hearing device for sensorineural hearing impairment. Otolaryngol Clin North Am 34:373\u2013388. https:\/\/doi.org\/10.1016\/S0030-6665(05)70337-6","journal-title":"Otolaryngol Clin North Am"},{"key":"7795_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/0194599813486255","volume":"149","author":"L Colletti","year":"2013","unstructured":"Colletti L, Mandal\u00e0 M, Colletti V (2013) Long-term outcome of round window Vibrant SoundBridge implantation in extensive ossicular chain defects. Otolaryngol Head Neck Surg 149:134\u2013141. https:\/\/doi.org\/10.1177\/0194599813486255","journal-title":"Otolaryngol Head Neck Surg"},{"key":"7795_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/14670100.2017.1358913","volume":"18","author":"S Labassi","year":"2017","unstructured":"Labassi S, Beliaeff M, P\u00e9an V et al (2017) The Vibrant Soundbridge\u00ae middle ear implant: a historical overview. Cochlear Implants Int 18:314\u2013323. https:\/\/doi.org\/10.1080\/14670100.2017.1358913","journal-title":"Cochlear Implants Int"},{"key":"7795_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1044\/2019_AJA-18-0066","volume":"28","author":"U Geiger","year":"2019","unstructured":"Geiger U, Radeloff A, Hagen R et al (2019) Intraoperative estimation of the coupling efficiency and clinical outcomes of the vibrant soundbridge active middle ear implant using auditory brainstem response measurements. Am J Audiol 28:553\u2013559. https:\/\/doi.org\/10.1044\/2019_AJA-18-0066","journal-title":"Am J Audiol"},{"key":"7795_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000275062","volume":"56","author":"GM Sprinzl","year":"2010","unstructured":"Sprinzl GM, Riechelmann H (2010) Current trends in treating hearing loss in elderly people: a review of the technology and treatment options\u2014a mini-review. Gerontology 56:351\u2013358. https:\/\/doi.org\/10.1159\/000275062","journal-title":"Gerontology"},{"key":"7795_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00129492-200305000-00013","volume":"24","author":"O Sterkers","year":"2003","unstructured":"Sterkers O, Boucarra D, Labassi S et al (2003) A middle ear implant, the Symphonix Vibrant Soundbridge: retrospective study of the first 125 patients implanted in France. Otol Neurotol 24:427\u2013436. https:\/\/doi.org\/10.1097\/00129492-200305000-00013","journal-title":"Otol Neurotol"},{"key":"7795_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/01.mao.0000199754.51815.70","volume":"27","author":"N Schmuziger","year":"2006","unstructured":"Schmuziger N, Schimmann F, \u00e0Wengen D et al (2006) Long-term assessment after implantation of the Vibrant Soundbridge device. Otol Neurotol 27:183\u2013188. https:\/\/doi.org\/10.1097\/01.mao.0000199754.51815.70","journal-title":"Otol Neurotol"},{"key":"7795_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000318522","volume":"69","author":"SM Pok","year":"2010","unstructured":"Pok SM, Schl\u00f6gel M, B\u00f6heim K (2010) Clinical experience with the active middle ear implant Vibrant Soundbridge in sensorineural hearing loss. Adv Otorhinolaryngol 69:51\u201358. https:\/\/doi.org\/10.1159\/000318522","journal-title":"Adv Otorhinolaryngol"},{"key":"7795_CR38","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/lary.25670","volume":"126","author":"A Ernst","year":"2016","unstructured":"Ernst A, Todt I, Wagner J (2016) Safety and effectiveness of the Vibrant Soundbridge in treating conductive and mixed hearing loss: a systematic review. Laryngoscope 126:1451\u20131457. https:\/\/doi.org\/10.1002\/lary.25670","journal-title":"Laryngoscope"},{"key":"7795_CR39","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00405-016-4361-2","volume":"274","author":"K-L Bruchhage","year":"2017","unstructured":"Bruchhage K-L, Leichtle A, Sch\u00f6nweiler R et al (2017) Systematic review to evaluate the safety, efficacy and economical outcomes of the Vibrant Soundbridge for the treatment of sensorineural hearing loss. Eur Arch Otorhinolaryngol 274:1797\u20131806. https:\/\/doi.org\/10.1007\/s00405-016-4361-2","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"7795_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/lio2.215","volume":"3","author":"MK Klie\u00df","year":"2018","unstructured":"Klie\u00df MK, Ernst A, Wagner J et al (2018) The development of active middle ear implants: A historical perspective and clinical outcomes. Laryngosc Investig Otolaryngol 3:394\u2013404. https:\/\/doi.org\/10.1002\/lio2.215","journal-title":"Laryngosc Investig Otolaryngol"},{"key":"7795_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/MAO.0b013e31818be812","volume":"30","author":"T Linder","year":"2009","unstructured":"Linder T, Schlegel C, DeMin N et al (2009) Active middle ear implants in patients undergoing subtotal petrosectomy: new application for the Vibrant Soundbridge device and its implication for lateral cranium base surgery. Otol Neurotol 30:41\u201347. https:\/\/doi.org\/10.1097\/MAO.0b013e31818be812","journal-title":"Otol Neurotol"},{"key":"7795_CR42","unstructured":"(2021) ISO 8253-1:2010(en), Acoustics\u2014audiometric test methods\u2014part 1: Pure-tone air and bone conduction audiometry. https:\/\/www.iso.org\/obp\/ui\/#iso:std:iso:8253:-1:ed-2:v1:en. Accessed 27 Nov 2021"},{"key":"7795_CR43","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00106-018-0524-3","volume":"66","author":"S Lailach","year":"2018","unstructured":"Lailach S, Baumann I, Zahnert T et al (2018) Aktueller Stand der Lebensqualit\u00e4tsmessung bei Patienten mit chronischer Otitis media und Schallleitungsschwerh\u00f6rigkeit (State of the art of quality-of-life measurement in patients with chronic otitis media and conductive hearing loss). HNO 66:578\u2013589. https:\/\/doi.org\/10.1007\/s00106-018-0524-3","journal-title":"HNO"},{"key":"7795_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/000348949610500601","volume":"105","author":"K Robinson","year":"1996","unstructured":"Robinson K, Gatehouse S, Browning GG (1996) Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 105:415\u2013422. https:\/\/doi.org\/10.1177\/000348949610500601","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"7795_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/coa.12518","volume":"41","author":"J Hendry","year":"2016","unstructured":"Hendry J, Chin A, Swan IRC et al (2016) The Glasgow Benefit Inventory: a systematic review of the use and value of an otorhinolaryngological generic patient-recorded outcome measure. Clin Otolaryngol 41:259\u2013275. https:\/\/doi.org\/10.1111\/coa.12518","journal-title":"Clin Otolaryngol"},{"key":"7795_CR46","doi-asserted-by":"publisher","first-page":"e0191047","DOI":"10.1371\/journal.pone.0191047","volume":"13","author":"S Graspeuntner","year":"2018","unstructured":"Graspeuntner S, Bohlmann MK, Gillmann K et al (2018) Microbiota-based analysis reveals specific bacterial traits and a novel strategy for the diagnosis of infectious infertility. PLoS ONE 13:e0191047. https:\/\/doi.org\/10.1371\/journal.pone.0191047","journal-title":"PLoS ONE"},{"key":"7795_CR47","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1038\/s41598-018-27757-8","volume":"8","author":"S Graspeuntner","year":"2018","unstructured":"Graspeuntner S, Loeper N, K\u00fcnzel S et al (2018) Selection of validated hypervariable regions is crucial in 16S-based microbiota studies of the female genital tract. Sci Rep 8:9678. https:\/\/doi.org\/10.1038\/s41598-018-27757-8","journal-title":"Sci Rep"},{"key":"7795_CR48","doi-asserted-by":"publisher","first-page":"2038855","DOI":"10.1080\/19490976.2022.2038855","volume":"14","author":"V Bossung","year":"2022","unstructured":"Bossung V, Lupatsii M, Dashdorj L et al (2022) Timing of antimicrobial prophylaxis for cesarean section is critical for gut microbiome development in term born infants. Gut Microbes 14:2038855. https:\/\/doi.org\/10.1080\/19490976.2022.2038855","journal-title":"Gut Microbes"},{"key":"7795_CR49","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","volume":"75","author":"PD Schloss","year":"2009","unstructured":"Schloss PD, Westcott SL, Ryabin T et al (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537\u20137541. https:\/\/doi.org\/10.1128\/AEM.01541-09","journal-title":"Appl Environ Microbiol"},{"key":"7795_CR50","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nbt.4229","volume":"36","author":"DH Parks","year":"2018","unstructured":"Parks DH, Chuvochina M, Waite DW et al (2018) A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat Biotechnol 36:996\u20131004. https:\/\/doi.org\/10.1038\/nbt.4229","journal-title":"Nat Biotechnol"},{"key":"7795_CR51","unstructured":"R Core Team (2020) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/"},{"key":"7795_CR52","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3109\/00016489.2012.684701","volume":"132","author":"K B\u00f6heim","year":"2012","unstructured":"B\u00f6heim K, Mlynski R, Lenarz T et al (2012) Round window vibroplasty: long-term results. Acta Otolaryngol 132:1042\u20131048. https:\/\/doi.org\/10.3109\/00016489.2012.684701","journal-title":"Acta Otolaryngol"},{"key":"7795_CR53","doi-asserted-by":"publisher","DOI":"10.1159\/000516144","author":"SH Edlinger","year":"2021","unstructured":"Edlinger SH, Hasenzagl M, Schoerg P et al (2021) Long-term safety and quality of life after vibroplasty in sensorineural hearing loss: short\/long incus process coupler. Audiol Neurootol. https:\/\/doi.org\/10.1159\/000516144","journal-title":"Audiol Neurootol"},{"key":"7795_CR54","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.ijporl.2012.08.022","volume":"76","author":"S Roman","year":"2012","unstructured":"Roman S, Denoyelle F, Farinetti A et al (2012) Middle ear implant in conductive and mixed congenital hearing loss in children. Int J Pediatr Otorhinolaryngol 76:1775\u20131778. https:\/\/doi.org\/10.1016\/j.ijporl.2012.08.022","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"7795_CR55","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3109\/00016489.2013.765969","volume":"133","author":"P Clar\u00f3s","year":"2013","unstructured":"Clar\u00f3s P, Del Pujol MC (2013) Active middle ear implants: Vibroplasty\u2122 in children and adolescents with acquired or congenital middle ear disorders. Acta Otolaryngol 133:612\u2013619. https:\/\/doi.org\/10.3109\/00016489.2013.765969","journal-title":"Acta Otolaryngol"},{"key":"7795_CR56","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/lio2.460","volume":"5","author":"JC Nogues","year":"2020","unstructured":"Nogues JC, P\u00e9rez-Losada M, Preciado D (2020) Review of otitis media microbiome studies: What do they tell us? Laryngosc Investig Otolaryngol 5:936\u2013940. https:\/\/doi.org\/10.1002\/lio2.460","journal-title":"Laryngosc Investig Otolaryngol"},{"key":"7795_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12866-018-1154-3","volume":"18","author":"R Lappan","year":"2018","unstructured":"Lappan R, Imbrogno K, Sikazwe C et al (2018) A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera. BMC Microbiol 18:13. https:\/\/doi.org\/10.1186\/s12866-018-1154-3","journal-title":"BMC Microbiol"},{"key":"7795_CR58","unstructured":"Deutsche Gesellschaft f\u00fcr Hals-Nasen-Ohrenheilkunde 017\/066_S2k-Leitlinie-Antibiotikatherapie_der_Infektionen_an_Kopf_und_Hals_2019\u201311_1"},{"key":"7795_CR59","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/j.1462-5822.2009.01323.x","volume":"11","author":"L Hall-Stoodley","year":"2009","unstructured":"Hall-Stoodley L, Stoodley P (2009) Evolving concepts in biofilm infections. Cell Microbiol 11:1034\u20131043. https:\/\/doi.org\/10.1111\/j.1462-5822.2009.01323.x","journal-title":"Cell Microbiol"},{"key":"7795_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18073555","author":"A Niedzielski","year":"2021","unstructured":"Niedzielski A, Chmielik LP, Stankiewicz T (2021) The formation of biofilm and bacteriology in otitis media with effusion in children: a prospective cross-sectional study. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph18073555","journal-title":"Int J Environ Res Public Health"},{"key":"7795_CR61","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3389\/fgene.2019.01176","volume":"10","author":"Q Xu","year":"2019","unstructured":"Xu Q, Gill S, Xu L et al (2019) comparative analysis of microbiome in nasopharynx and middle ear in young children with acute otitis media. Front Genet 10:1176. https:\/\/doi.org\/10.3389\/fgene.2019.01176","journal-title":"Front Genet"},{"key":"7795_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","volume":"10","author":"R Enaud","year":"2020","unstructured":"Enaud R, Prevel R, Ciarlo E et al (2020) The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol 10:9. https:\/\/doi.org\/10.3389\/fcimb.2020.00009","journal-title":"Front Cell Infect Microbiol"},{"key":"7795_CR63","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2174\/1570159X16666180118101354","volume":"16","author":"I Mack","year":"2018","unstructured":"Mack I, Penders J, Cook J et al (2018) Is the impact of starvation on the gut microbiota specific or unspecific to anorexia nervosa? A narrative review based on a systematic literature search. Curr Neuropharmacol 16:1131\u20131149. https:\/\/doi.org\/10.2174\/1570159X16666180118101354","journal-title":"Curr Neuropharmacol"},{"key":"7795_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.humic.2016.09.001","volume":"1","author":"M Tidjani Alou","year":"2016","unstructured":"Tidjani Alou M, Lagier J-C, Raoult D (2016) Diet influence on the gut microbiota and dysbiosis related to nutritional disorders. Human Microbiome J 1:3\u201311. https:\/\/doi.org\/10.1016\/j.humic.2016.09.001","journal-title":"Human Microbiome J"},{"key":"7795_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, Wang J, He T et al (2018) Butyrate: a double-edged sword for health? Adv Nutr 9:21\u201329. https:\/\/doi.org\/10.1093\/advances\/nmx009","journal-title":"Adv Nutr"},{"key":"7795_CR66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne) 11:25. https:\/\/doi.org\/10.3389\/fendo.2020.00025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7795_CR67","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00355-19","author":"T Lachnit","year":"2019","unstructured":"Lachnit T, Bosch TCG, Deines P (2019) Exposure of the host-associated microbiome to nutrient-rich conditions may lead to dysbiosis and disease development-an evolutionary perspective. MBio. https:\/\/doi.org\/10.1128\/mBio.00355-19","journal-title":"MBio"},{"key":"7795_CR68","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nri2515","volume":"9","author":"JL Round","year":"2009","unstructured":"Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:313\u2013323. https:\/\/doi.org\/10.1038\/nri2515","journal-title":"Nat Rev Immunol"},{"key":"7795_CR69","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1017\/S0007114519000680","volume":"122","author":"G Precup","year":"2019","unstructured":"Precup G, Vodnar D-C (2019) Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review. Br J Nutr 122:131\u2013140. https:\/\/doi.org\/10.1017\/S0007114519000680","journal-title":"Br J Nutr"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07795-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-022-07795-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07795-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T11:07:36Z","timestamp":1685099256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-022-07795-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["7795"],"URL":"https:\/\/doi.org\/10.1007\/s00405-022-07795-9","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. All authors have no relationship with the company that sells the implant device; also the company does financially not support the data presented.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}